Halozyme Therapeutics
HALO
#2323
Rank
S$8.70 B
Marketcap
$68.68
Share price
-2.21%
Change (1 day)
33.66%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): S$0.56 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$0.87 Billion. In 2023 the company made an earning of S$0.45 Billion, an increase over its 2022 earnings that were of S$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.56 B22.79%
2023 S$0.45 B39.94%
2022 S$0.32 B0.16%
2021 S$0.32 B92.2%
2020 S$0.16 B-278.96%
2019 -S$94.92 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$80.93 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$42.35 Million-52.86%
2014 -S$89.83 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$70.36 Million169.94%
2011 -S$26.07 Million-63.44%
2010 -S$71.28 Million-7.19%
2009 -S$76.8 Million15.91%
2008 -S$66.26 Million83.89%
2007 -S$36.04 Million78.1%
2006 -S$20.24 Million16%
2005 -S$17.45 Million45.24%
2004 -S$12.01 Million682.42%
2003 -S$1.54 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$18.24 M-96.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$11.80 B 2,057.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$98.53 Million-118.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.6 Billion-390.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.86 B 1,519.79%๐Ÿ‡ซ๐Ÿ‡ท France
S$26.63 B 4,765.06%๐Ÿ‡บ๐Ÿ‡ธ USA